ISRCTN46911260已完成3 期
Vascular Augmentation of Late-life Unremitted Depression: a randomised study
Gateshead Health NHS Foundation Trust (UK)0 个研究点目标入组 8 人开始时间: 2012年1月31日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 50 years and over
- •2. Clinically significant (unremitted) vascular depression, as defined above
- •3. Mini mental state examination (MMSE) >23
- •4. Medically stable
- •5. BP < 150/90 (QoF Audit standard)
- •6. Patient has provided written informed consent for participation in the study prior to any study specific procedures. ; Lower Age Limit 50 years
排除标准
- •1. Taking a calcium channel blocker
- •2. Clinical evidence of dementia
- •3. History or clinical evidence of stroke
- •4. History of bipolar or psychotic disorder
- •5. Significant suicide risk
- •6. Known hypersensitivity to amlodipine or any other calcium channel blocker
- •7. Severe renal or hepatic impairment
- •8. Pregnancy, or women planning to become pregnant within next 12 months, or women who are breast feeding
- •9. Use of other investigational study drugs within 30 days prior to study entry (defined as date of randomisation into study)
- •10. Previous participation in this study
- •11. Presence of cardiac pace-maker or other contraindications to (only applies to those consenting to MRI sub-study)
研究者
相似试验
进行中（未招募）
1 期
Adding a medication, amlodipine, to the treatment of older people with a type of depression that has not responded to previous treatment.ate-life (aged 50 or over) unremitted vascular depression.MedDRA version: 14.0 Level: PT Classification code 10012378 Term: Depression System Organ Class: 10037175 - Psychiatric disordersEUCTR2010-023969-21-GBGateshead Health NHS Foundation Trust8
已完成
Unknown
Evaluation of two dental materials in regenerative treatment of non-vital teeth with incomplete root developmentTreatment of necrotic immature teeth with apical periodontitisOral HealthISRCTN69846868Damascus University20
已完成
1 期
Angiogenesis augmentation therapy for indirect revascularization of moyamoya disease using G-CSFMoyamoya diseaseMoyamoya disease, indirect revascularization, Granulocyte-Colony Stimulating FactorD009072JPRN-jRCTs071220048Morioka Motohiro5
已完成
Unknown
Stem cell transplantation for vascular regeneration in the legsChronic critical limb ischemia (peripheral arterial disease, Buerger disease)JPRN-jRCT2090220022Atsuhiko Kawamoto11
招募中
不适用
Effectiveness of Additional Endovascular Treatement in patients with Acute Symptomatic Internal Carotid Artery Occlusion and receving IV tPADiseases of the nervous systemKCT0001129Seoul National University Bundang Hospital249